Capital International Sarl’s Quest Diagnostics DGX Stock Holding History

Capital International Sarl’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,000	Closed	-$123K	–	164
2015 Q3	$123K	Sell	2,000 -800	-29%	-$55.9K	0.01%	154
2015 Q2	$203K	Sell	2,800 -3,000	-52%	-$222K	0.02%	154
2015 Q1	$446K	Sell	5,800 -5,000	-46%	-$358K	0.03%	136
2014 Q4	$724K	Sell	10,800 -4,300	-28%	-$271K	0.04%	122
2014 Q3	$916K	Sell	15,100 -10,800	-42%	-$665K	0.05%	113
2014 Q2	$1.52M	Buy	25,900 +4,000	+18%	+$234K	0.09%	101
2014 Q1	$1.27M	Buy	21,900 +2,500	+13%	+$134K	0.07%	104
2013 Q4	$1.04M	Buy	19,400 +1,200	+7%	+$71.2K	0.06%	103
2013 Q3	$1.13M	Buy	+18,200	New	+$1.09M	0.06%	99

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Sarl's DGX Position: Q4 2015 in Review

Capital International Sarl sold out of Quest Diagnostics (DGX) in Q4 2015, closing a stake of 2,000 shares — an estimated $123K sold.

Capital International Sarl first reported a position in DGX in Q3 2013 and held it in 9 quarters. The position peaked at $1.52M in Q2 2014. 535 funds tracked by Wall St. Rank hold DGX as of Q4 2015.

Capital International Sarl reported no remaining Quest Diagnostics position as of Q4 2015 after selling out during the quarter.
Capital International Sarl sold 2,000 Quest Diagnostics shares in Q4 2015, an estimated $123K.
Capital International Sarl first reported a position in Quest Diagnostics in Q3 2013 and held it in 9 quarters.
Capital International Sarl's Quest Diagnostics position peaked at $1.52M in Q2 2014.
535 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2015.

Based on Capital International Sarl's 13F filing for Q4 2015, filed 12 Feb 2016.